Arm Skeletal Muscle Mass Is Associated With the Prognosis of Patients With Cirrhosis.


Journal

In vivo (Athens, Greece)
ISSN: 1791-7549
Titre abrégé: In Vivo
Pays: Greece
ID NLM: 8806809

Informations de publication

Date de publication:
Historique:
received: 10 01 2020
revised: 24 01 2020
accepted: 29 01 2020
entrez: 2 5 2020
pubmed: 2 5 2020
medline: 9 2 2021
Statut: ppublish

Résumé

This study aimed to assess the clinical significance of measuring the arm skeletal muscle mass in patients with cirrhosis. Using body composition data measured with the bioimpedance analysis (BIA) method, the skeletal muscle mass index (SMI) values of the arm (arm skeletal muscle mass/height Arm SMI was significantly positively associated with the prognosis of patients with cirrhosis (p=0.0002) but leg SMI was not (p=0.0829). The rate of overhydration in the lower limbs was significantly higher than that in the upper limbs (p<0.0001). Arm SMI measured with the BIA method was suggested to be minimally affected by water retention, and might be clinically useful for patients with cirrhosis.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
This study aimed to assess the clinical significance of measuring the arm skeletal muscle mass in patients with cirrhosis.
PATIENTS AND METHODS METHODS
Using body composition data measured with the bioimpedance analysis (BIA) method, the skeletal muscle mass index (SMI) values of the arm (arm skeletal muscle mass/height
RESULTS RESULTS
Arm SMI was significantly positively associated with the prognosis of patients with cirrhosis (p=0.0002) but leg SMI was not (p=0.0829). The rate of overhydration in the lower limbs was significantly higher than that in the upper limbs (p<0.0001).
CONCLUSION CONCLUSIONS
Arm SMI measured with the BIA method was suggested to be minimally affected by water retention, and might be clinically useful for patients with cirrhosis.

Identifiants

pubmed: 32354906
pii: 34/3/1165
doi: 10.21873/invivo.11889
pmc: PMC7279841
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1165-1171

Informations de copyright

Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Références

J Am Med Dir Assoc. 2014 Feb;15(2):95-101
pubmed: 24461239
J Am Med Dir Assoc. 2011 May;12(4):249-56
pubmed: 21527165
J Gerontol A Biol Sci Med Sci. 2014 May;69(5):547-58
pubmed: 24737557
World J Hepatol. 2013 Aug 27;5(8):433-8
pubmed: 24023982
Lancet. 2019 Jun 29;393(10191):2636-2646
pubmed: 31171417
Age Ageing. 2010 Jul;39(4):412-23
pubmed: 20392703
Nutrients. 2018 Aug 12;10(8):
pubmed: 30103528
Hepatol Res. 2014 Oct;44(10):E316-7
pubmed: 25257689
J Gastroenterol. 2020 Mar;55(3):353-362
pubmed: 31768801
In Vivo. 2020 Mar-Apr;34(2):687-693
pubmed: 32111771
Liver Int. 2018 May;38(5):851-857
pubmed: 29323441
J Nutr. 1997 May;127(5 Suppl):990S-991S
pubmed: 9164280
J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):347-354
pubmed: 30793533
Hepatol Res. 2016 Sep;46(10):951-63
pubmed: 27481650
J Hum Nutr Diet. 2016 Feb;29(1):7-25
pubmed: 25420774
Nutr Diet. 2019 Nov;76(5):613-619
pubmed: 30869199
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
J Hepatobiliary Pancreat Sci. 2017 Jul;24(7):409-416
pubmed: 28371518
Arq Gastroenterol. 2018 Jan-Mar;55(1):2-6
pubmed: 29561971
Nutrition. 1993 Jul-Aug;9(4):339-43
pubmed: 8400590

Auteurs

Yoshihiro Shimono (Y)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

Hirayuki Enomoto (H)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan enomoto@hyo-med.ac.jp.

Kyohei Kishino (K)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

Ei-Ichiro Moriwaki (EI)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.
Department of Gastroenterology, Kano General Hospital, Osaka, Japan.

Hiroki Nishikawa (H)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

Takashi Nishimura (T)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

Yoshinori Iwata (Y)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

Hiroko Iijima (H)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

Shuhei Nishiguchi (S)

Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH